date:Jul 30, 2015
he worlds economic output that would boost growth and put pressure on Chinanot part of the talksto accelerate reform and liberalize its economy.
However, the talks between the U.S., Japan, Canada, Malaysia, Australia and the seven other members have been difficult, triggering disputes on several matters, including the U.S. position on pharmaceutical patents and on how state-owned businesses should be treated.
Negotiators are split over the best approach to patenting biologic medicines, treatmen